Mestre-Venice, October 25 th -26 th NH Laguna Palace Hotel Mestre, Venice

Transcription

1 3 rd edition Mestre-Venice, October 25 th -26 th 2018 NH Laguna Palace Hotel Mestre, Venice Chairman Matteo Bassetti (Italy) Co-Chairman David P. Nicolau (USA) International Scientific committee A. Brink (South Africa), T. Calandra (Switzerland), G. Dimopulos (Greece), C. Eckmann (Germany), R. Kozlov (Russia), P. Munoz (Spain), J.F. Timsit (France), M.V. Villegas (Colombia), M. Wilcox (UK) SCIENTIFIC PROGRAM Organized under the auspicies of Azienda Sanitaria Universitaria Integrata di Udine

2 3 rd edition SCIENTIFIC 08:30 08:45 Registration 08:45 09:00 Welcome and introduction - M. Bassetti (Italy) 09:00 10:40 Antimicrobial stewardship: can we do it better? Chair: S. Brusaferro (Italy), S. Stefani (Italy) 09:00 09:20 Bacteria and drugs now and in the next 30 years: who will be the winner? - G. Rossolini (Italy) 09:20 09:40 Impact of antimicrobial stewardship programs - A. Brink (South Africa) 09:40 10:00 How to develop a perfect program - E. Tacconelli (Italy) 10:00 10:20 Limitation of actual program of AMS and future directions - M.V. Villegas (Colombia) 10:20 10:40 Antifungal stewardship: how to do it? - E. Bouza (Spain) 10:40 11:00 Coffee Break 11:00 12:00 Recurrent C. difficile infection: kill the bug or cure the microbiome? Chair: F. Menichetti (Italy) 11:00 11:20 Introduction: C. difficile recurrence a disregarded medical challenge? - F. Menichetti (Italy) 11:20 11:40 Management of rec C. difficile infections: cure of symptoms or cure of the disease? - M. Wilcox (UK) 11:40 12:00 Prevention of C. difficile recurrence: evidence from a C. difficile antitoxin - E. Bouza (Spain) 12:00 13:00 Early adequate antibiotic therapy for MDR infections Chair: P.L. Viale (Italy), N. Petrosillo (Italy) 12:00 12:30 Managing serious Gram-positive infections appropriately - M. Dryden (UK) 12:30 13:00 Therapy of MDR/XDR Gram-negative bacteria: dealing with the evil - A. Soriano (Spain) 13:00 14:30 Lunch and poster walk with discussion

3 Mestre-Venice, October 25 th -26 th 2018 PROGRAM October 25 th :30 15:00 An update in the management of community-acquired Pneumonia in an era of increasing antimicrobial resistance and antimicrobial stewardship - J. Garau (Spain) Chair: F. Blasi (Italy) 15:00 16:30 How to manage a septic patient in clinical practice Chair: C. Tascini (Italy), M. Venditti (Italy) 15:00 15:20 How to balance the need of the society and the need of the septic patient? - Y. Carmeli (Istrael) 15:20 15:40 Should we reduce mortality with an appropriate antibiotic treatment? - T. Calandra (Switzerland) 15:40 16:00 Are the new definition affecting the management of sepsis? - J. De Waele (Belgium) 16:00 16:20 Is the source control more important than antibiotics? - P. Montravers (France) 16:20 16:30 Discussion 16:30 17:00 Overview of antifungal strategies for severe mould infections - P. Munoz (Spain) Chair: L. Pagano (Italy) 17:00 18:30 Overview of next generation antibiotics Chair: D. Nicolau (USA), J. Garau (Spain) 17:00 17:30 New carbapenem combinations: - meropenem/vaborbactam - M. Bassetti (Italy) - imipenem/relebactam - A. Shorr (USA) - meropenem/nacubactam - M. Tumbarello (Italy) 17:30 17:40 Other betalactamase inhibitors combinations - D. Nicolau (USA) 17:40 17:50 Cefiderocol: a novel siderophore cephalosporin - P. L. Viale (Italy) 17:50 18:00 Eravacycline: a novel fluorocycline developed for the treatment of ciai - M. Bassetti (Italy) 18:00 18:10 Omadacycline: a novel tetracycline subclass antibiotics - P. Montravers (France) 18:10 18:20 Delafloxacin: a novel fluoroquinolone antibiotic - J. Garau (Spain) 18:20 18:30 Lefamulin: a novel pleuromutilin antibiotic class - G. Dimopoulos (Greece)

4 3 rd edition SCIENTIFIC 08:30 10:15 Critically ill patients and difficult to treat bugs: a challenging scenario Chair: M. Girardis (Italy), F. De Rosa (Italy) 08:30 08:45 The eternal dilemma for non-fermenters: monotherapy or combination? - T. Calandra (Switzerland) 08:45 09:00 Optimization of PK/PD of antibiotics for resistant Gram-negative organisms - F. Pea (Italy) 09:00 09:15 A.baumannii js just a bad marker for prognosis or a real killer? - M. Akova (Turkey) 09:15 09:30 CRE can we define a universal strategic treatment management? - D. Nicolau (USA) 09:30 09:45 Serious MRSA infection: anything new? - M. Wilcox (UK) 09:45 10:00 Any role for old antibiotics? - G. Dimopoulos (Greece) 10:00 10:15 When do we need to treat Candida empirically? - J.F. Timsit (France) 10:15 10:30 Coffee Break 10:30 12:00 New directions and evidences in the management of complicated skin and skin structure infections Chair: F. Menichetti (Italy), C. Eckmann (Germany) 10:30 10:50 How to stratify the risk of MDR in cssti and how to be appropriate - A. Shorr (USA) 10:50 11:10 Novel therapeutic approaches for cssti - M. Dryden (UK) 11:10 11:30 The role of long acting antibiotics - A. Soriano (Spain) 11:30 11:50 The role of new fluoroquinolones - C. Eckmann (Germany) 11:50 12:00 Discussion 12:00 13:00 Main Consideration for Recognizing and Best Managing Patients with Critical Pseudomonal Infections Chair: M. Bassetti (Italy) 12:00 12:30 Difficult to treat Gram(-) infections: implication of epidemiology and local ecology data to treatment strategies - J.F. Timsit (France) 12:30 13:00 Latest evidence and guidelines on new antibiotics - What antibiotic for which patient? - M. Bassetti (Italy) 13:00 14:30 Lunch and poster walk with discussion

5 Mestre-Venice, October 25 th -26 th 2018 PROGRAM October 26 th :30 15:30 Rezafungin: a novel echinocandin for Treatment and Prevention of IFI Chair: M. Bassetti (Italy) 14:30 15:00 Prevention and management of fungal infections: we can do better - R. Lewis (Italy) 15:00 15:30 New options for prevention & treatment of IFI - T. Sandison (USA) 15:30 17:00 New and rapid diagnostic methods Chair: G. Rossolini (Italy) 15:30 16:00 New diagnostic methods for fungal infections - M. Sanguinetti (Italy) 16:00 16:30 New diagnostic methods for hepatitis - S. Chevaliez (France) 16:30 17:00 New diagnostic methods for early identification of bacteria - D. Nicolau (USA) 17:00 17:30 Final test and conclusions

6 Scientific Secretariat Professor Matteo Bassetti, MD PhD Head, Infectious Diseases Clinic Univesity of Udine and Santa Maria Misericordia University Hospital Udine - Italy Tel Fax matteo.bassetti@asuiud.sanita.fvg.it Congress Venue Hotel NH Laguna Palace Viale Ancona, Mestre, Venice Italy CME Accreditation The Conference was granted 9,8 CME creditis by Age.Na.S. for the following specialities: BIOLOGO INFERMIERE FARMACISTA OSPEDALIERO MEDICO CHIRURGO specialista in: Anestesia e Rianimazione; Chirurgia Generale; Dermatologia e Venereologia; Ematologia; Epidemiologia; Farmacologia e Tossicologia Clinica; Gastroenterologia; Malattie dell apparato Respiratorio; Malattie Infettive; Medicina Interna; Microbiologia e Virologia; Nefrologia; Oncologia. Organizing Secretariat Academy srl via Aosta 4/A Milan-Italy Tel Fax info@academy-congressi.it luigi.parravicini@academy-congressi.it